Country: France
Language: English
Source: HMA (Heads of Medicines Agencies)
tiamulin 10.12 mg/ml
CEVA Santé Animale
QJ01XX92
Oral solution
tiamulin
Chicken, Pigs, Turkeys
2011-04-17
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT TIAMVET 125 mg/ml oral solution [CZ, HU,PT] TIAMULINE SOLUTION CEVA [FR] 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One ml contains: Active ingredient: Tiamulin 101.2 mg equivalent to Tiamulin hydrogen fumarate..................................................................125.0 mg Excipient Benzyl alcohol (E1519) ......................................................................... 15.0 mg For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Oral solution. Clear colourless to pale yellow solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Chickens, turkeys and pigs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Chickens and turkeys: Treatment and prevention of chronic respiratory disease caused by tiamuline susceptible strains : _Mycoplasma gallisepticum_, _Mycoplasma meleagridis_. Pigs: Treatment of enzootic pneumonia caused by tiamulin susceptible strains : _Mycoplasma hyopneumoniae, _ _Mycoplasma hyorhinis. _ Treatment of haemorragic enteritis caused by or complicated by tiamulin susceptible strains : _Brachyspira _ _hyodysenteriae._ 4.3 CONTRAINDICATIONS Do not administer the product with monensin, salinomycin and narasin and other monovalent ionophore- antibiotics 7 days before, during and 7 days after treatment of animals. Do not use in animals with known hypersensitivity to tiamulin or any excipients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES For pigs: The uptake of medication by animals can be altered as a consequence of illness. For animals wi Read the complete document